Comparing BPC-157 and TB-500 (Thymosin Beta-4) — both manufactured and packaged entirely in GMP-compliant United States facilities. This research-use reference summarizes how each is classified and what each has been studied for.
Comparing BPC-157 and TB-500 (Thymosin Beta-4) — both manufactured and packaged entirely in GMP-compliant United States facilities. This research-use reference summarizes how each is classified and what each has been studied for.
BPC-157 is a tissue repair peptide. Studied for accelerated repair of tendon, ligament, muscle and gut lining via angiogenesis and cellular migration to injury sites. Our BPC-157 is manufactured and packaged entirely in GMP-compliant United States facilities and third-party COA tested.
TB-500 (Thymosin Beta-4) is a regeneration peptide. Investigated for promoting cell migration, blood-vessel formation and flexibility during soft-tissue and muscle-fiber recovery. Our TB-500 (Thymosin Beta-4) is manufactured and packaged entirely in GMP-compliant United States facilities and third-party COA tested.
Both BPC-157 and TB-500 (Thymosin Beta-4) from PX1 are manufactured and packaged entirely in GMP-compliant United States facilities, with ISO 17025 third-party COAs available. All material is sold for laboratory and research use only — this page does not offer medical guidance or dosing.
What is the difference between BPC-157 and TB-500 (Thymosin Beta-4)?
BPC-157 is a tissue repair peptide; TB-500 (Thymosin Beta-4) is a regeneration peptide. Each has a distinct research profile — see the sections above.
Are both made in the USA?
Yes — both are manufactured and packaged entirely in GMP-compliant United States facilities and ship with third-party COAs available.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.